Genomic profiling showed that ALK+ ALCL displays a homogeneous cytotoxic/Th1 signature in contrast to ALK- ALCL that has either a cytotoxic profile or a Th2-associated signature. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.